(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CORIS BIOCONCEPT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

CORIS BIOCONCEPT

ST13

US500000079355757

Class

5

Filing

79355757

Registration

7470093

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

43

Latest update

04/03/2026

Trademark type

Combined

Nice classes

5

Filing date

10/20/2022

Registration date

08/13/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/13/2024

Last transaction

04/03/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

99

Owner location

BE

Examiner

JOHNSON, AISHA CLARKE

Law office

L10

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of a stylized red "C" with a red sphere in the center; to the right of the design is the stylized black wording "CORIS BIOCONCEPT" on two lines; the entire mark is underlined in red.

Holders and representatives

Holders

C. S. (pessoa física)

Representatives

Burton S. Ehrlich Ladas & Parry LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Diagnostic preparations for medical or veterinary use for detecting viruses and parasites responsible for digestiveintestinal and respiratory problems; diagnostic productsnamely reagentstesting strips and diagnostic preparations for the detection of human respiratorygastro-enteric and blood-borne pathogens and for the detection of antibiotic resistance markers for medical or veterinary use; diagnostic kits for medical or veterinary use consisting primarily of buffers and reagents for use in rapid in vitro diagnostics of human infectious diseases; medical and pharmaceutical substances used in the production of diagnostic products for medical or veterinary usenamely diagnostic preparations for the detection of human respiratorygastro-enteric and blood-borne pathogens and for the detection of antibiotic resistance markers; diagnostic human respiratorygastro-enteric and blood-borne pathogens detection strips for medical use

Publications

History of USPTO decisions and trademark events.

43 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

02/21/2025

FICS

FINAL DISPOSITION NOTICE SENT TO IB

02/01/2025

FIMP

FINAL DISPOSITION PROCESSED

02/01/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

11/13/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

08/13/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

08/13/2024

GPNX

NOTIFICATION PROCESSED BY IB

07/14/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/28/2024

PUBO

PUBLISHED FOR OPPOSITION

05/28/2024

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

05/15/2024

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

05/15/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/08/2024

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

05/07/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/22/2024

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

04/17/2024

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

04/17/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/16/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/16/2024

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

04/16/2024

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

11/21/2023

GNFR

FINAL REFUSAL E-MAILED

11/21/2023

CNFR

FINAL REFUSAL WRITTEN

11/21/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/10/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/09/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/09/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/08/2023

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

11/08/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/08/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/08/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

11/08/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

11/08/2023

RFNT

REFUSAL PROCESSED BY IB

09/25/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

08/29/2023

RFRR

REFUSAL PROCESSED BY MPU

08/29/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

08/09/2023

CNRT

NON-FINAL ACTION WRITTEN

08/08/2023

DOCK

ASSIGNED TO EXAMINER

08/04/2023

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

05/16/2023

NREP

NEW REPRESENTATIVE AT IB RECEIVED

04/17/2023

MAFR

APPLICATION FILING RECEIPT MAILED

12/02/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/28/2022

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

11/25/2022

SDRC

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

11/17/2022

Continuous trademark protection

Get notified about every new filing that threatens CORIS BIOCONCEPT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.